Skip to content

Clinical trials

Phase 4 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 4 Clear all

234 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20025
20034
20044
20058
200616
20079
200812
200911
201016
201115
201212
201312
201412
201513
201613
20177
20185
20197
20206
20218
20225
202312
20249
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed155
Unknown status39
Recruiting15
Terminated15
Withdrawn6
Not yet recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emory University5
University of North Carolina, Chapel Hill4
Amgen3
Bausch & Lomb Incorporated3
Changi General Hospital3
Massachusetts General Hospital3
Oregon Health and Science University3
University Of Perugia3
University at Buffalo3
University of California, San Francisco3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation234
Atherosclerosis21
Diabetes Mellitus, Type 217
Insulin Resistance16
Coronary Artery Disease15
Pain14
Cardiovascular Diseases10
Kidney Failure, Chronic10
Obesity9
Thrombosis8

Trials

Showing 26 to 50 of 234. Each trial links to its page on Pharma Observatory.

134 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.